Record year comes as the rise of precision medicine drives a surge in demandPHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in 2024. The company enters 2025 having cemented its leadership position, with life sciences organizations and diagnostic laboratories increasingly deploying its Concentriq® enterprise pathology platform to advance the next novel therapies and diagnostics. “2024 was a breako ...

Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, today announced a strategic focus on targeting the NLRP3 inflammasome in all upcoming clinical trials. This shift aims to unlock new therapeutic potential for neurodegenerative diseases, longevity, and aging, positioning the Company at the forefront of innovation in neuroinflammation tre ...

"As we begin this exciting new chapter, Rezolve Ai believes it is well-positioned to lead the retail industry into a future defined by innovation, efficiency, and customer-centricity,†Wagner added. "With customers across multiple geographies, thriving partnerships, and groundbreaking payment advancements, we believe we are poised to transform how commerce is conducted globally.â€Â AI and Global Expansion Lead Rezolve Ai's Transformative Journey into the Future of Retail NEW YORK, Jan. 13, 2025 (GLOBE NEWSWI ...

Ward Guenther, founder of Whiskey Jam, said, "Whiskey Jam was founded back in 2011 as a chance for a bunch of friends to get together to play songs and party. There were a lot of writer's nights in town that had subdued atmospheres….we wanted to have one that was just a free-for-all, and that caught on so fast and it has evolved into a thing where when artists come to town it's on their list of things they gotta do; and it's on people's lists when they vacation here, 'gotta check out Whiskey Jam.' Nashville ...

NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptusâ€Â ), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that it has entered into securities purchase agreements with investors for the issuance and sale in a private placement priced at-the-market under Nasdaq rules of an aggregate of 2,109,383 of its shares of common stock and accompanying warrants to purchase up to an aggregate of ...

The CUSIP number for the Company's Ordinary Shares will be G8403L136. GRAND CAYMAN, Cayman Islands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH) ("SRIVARUâ€Â or the "Companyâ€Â ), a manufacturer of premium electric motorcycles, today announced that it will effect a share consolidation ("Reverse Share Splitâ€Â ) of its ordinary shares at a ratio of 50-for-1, effective as of 12:00 am on January 15, 2025 (the "Effective Timeâ€Â ), in order to regain compliance with the minimum $1.00 ...

Significantly Increases Deployment of Miners to Benefit from Rapidly Appreciating Bitcoin Prices LAS VEGAS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Bitmine Immersion Technologies, Inc. (“Bitmine” or the “Company”) (OTCQX: BMNR), a technology company focused on Bitcoin mining, today announced its operating results and operational update for its first fiscal quarter ended November 30, 2024: Bitmine Immersion Technologies, Inc.Condensed Statements of Operations (Unaudited) GAAP Non-GAAP <td style ...

Cash Runway into 2H 2026 to Achieve Key Milestones BRISBANE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced its 2025 outlook and key catalysts for its flagship programs: ANX005 in Guillain-Barré syndrome (GBS), ANX007 in geographic atrophy (GA), and oral small m ...

Company to Host Investor Day on March 13, 2025 RIDGEFIELD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the "Companyâ€Â or "Chefs'â€Â ), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today announced its preliminary outlook for fiscal year 2025. Based on current trends in the business, the Company is providing the following financial guidance for fiscal year 2025: Please see the schedule accompanying this release for ...

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year endedÂÂ December 31, 2024. The Company has not completed its standard accounting procedures in connection with its annual audit and, therefore, these results and any guidance remain preliminary and subject to further adjustment, including for potential impairments, write downs, and other non-cash or ...